Not exact matches
«To move the needle
forward toward prolonged survival and better treatment outcomes, our
research team created a combined investigational regimen for patients with locally advanced pancreatic cancer,» said Richard Tuli, MD, PhD, a radiation oncologist in the Department of Radiation
Oncology and a member of the Samuel Oschin Comprehensive Cancer Institute.
Lead author Professor Ledermann, professor of medical
oncology at the UCL Cancer Institute and a Cancer
Research UK grantee, said: «A well - tolerated anti-tumour agent that could be used for months or perhaps years as maintenance therapy after standard chemotherapy could be a big step
forward and ultimately extend survival.
I am truly humbled to be named the Embrace Kids Foundation Chair in Pediatric Hematology /
Oncology established in Dr. Kamen's memory, so that I can continue to carry his vision
forward in advancing pediatric cancer
research and keeping that «human» connection in treating the «whole» patient and not just the disease,» reflects Cole.